2/6
06:36 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
2/6
03:08 am
vrtx
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
Medium
Report
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
2/4
08:17 am
vrtx
Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial [Yahoo! Finance]
Low
Report
Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial [Yahoo! Finance]
2/3
07:06 pm
vrtx
Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today [Yahoo! Finance]
Low
Report
Here's How Much a $1000 Investment in Vertex Pharmaceuticals Made 10 Years Ago Would Be Worth Today [Yahoo! Finance]
2/2
10:29 pm
vrtx
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager [Yahoo! Finance]
Low
Report
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager [Yahoo! Finance]
2/2
10:22 pm
vrtx
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
Low
Report
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
2/2
10:21 pm
vrtx
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager [Globe and Mail, The (Toronto, Canada)]
Low
Report
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager [Globe and Mail, The (Toronto, Canada)]
2/2
10:17 pm
vrtx
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
Low
Report
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
2/2
10:08 pm
vrtx
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
Low
Report
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
2/1
01:43 am
vrtx
Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap [Yahoo! Finance]
Low
Report
Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap [Yahoo! Finance]
1/29
09:51 am
vrtx
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals [Yahoo! Finance]
Low
Report
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals [Yahoo! Finance]
1/29
07:00 am
vrtx
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Low
Report
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
1/28
08:01 am
vrtx
Here's Why Hardman Johnston Global Equity Strategy Sold Vertex Pharmaceuticals (VRTX) [Yahoo! Finance]
Low
Report
Here's Why Hardman Johnston Global Equity Strategy Sold Vertex Pharmaceuticals (VRTX) [Yahoo! Finance]
1/27
05:02 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/26
10:02 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/24
09:52 pm
vrtx
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval [Yahoo! Finance]
Low
Report
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval [Yahoo! Finance]
1/24
07:11 pm
vrtx
How Evolving Analyst Assumptions Are Reshaping The Story For Vertex Pharmaceuticals (VRTX) [Yahoo! Finance]
Low
Report
How Evolving Analyst Assumptions Are Reshaping The Story For Vertex Pharmaceuticals (VRTX) [Yahoo! Finance]
1/23
09:03 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/22
08:45 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
1/20
04:00 pm
vrtx
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
Medium
Report
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
1/15
08:09 pm
vrtx
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]
1/14
05:38 pm
vrtx
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report [Yahoo! Finance]
Low
Report
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report [Yahoo! Finance]
1/12
09:17 am
vrtx
Here's What Lifted Vertex Pharmaceuticals (VRTX) in Q4 [Yahoo! Finance]
Low
Report
Here's What Lifted Vertex Pharmaceuticals (VRTX) in Q4 [Yahoo! Finance]
1/12
07:17 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
1/11
07:40 pm
vrtx
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings [Yahoo! Finance]
Low
Report
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings [Yahoo! Finance]